Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT – a liver directed therapy for metastatic uveal melanoma.

You can read more at the article from their press release linked below!

Thank you Delcath Systems for your continued perseverance in the uveal melanoma space.